Our prestigious panel includes: Dr. Timothy Fong, MD; Dr. Gail E. Wyatt, PhD; Dr. Merrill Sparago, MD; Dr. Andrew Leuchter, MD; and Moderator Dr. Jonathan Shaywitz, MD. This panel discussion with doctors whose specialty is in psychiatry will help identify and define new evidence-based modalities for Treatment-Resistant Depression. Our experts will look at current strategies being employed including augmentation and will review new modalities such as TMS therapy. Learning Objectives: Define Treatment Resistant Depression. Describe current augmentation treatments for Treatment-Resistant Depression. Explain how current new modalities - including TMS, and other aspects in treating Treatment Resistant Depression. Analyze emerging data for Treatment-Resistant Depression.